iBio Inc.
IBIO | NASDAQ
$1.25
-$0.01 (-0.79%)
Sep 22, 2026, 12:14 PM ET · Market open
Fiscal Year Period Ending | FY 2026 Jun 29, 2026 | FY 2025 Jun 29, 2025 | FY 2024 Jun 29, 2024 | FY 2023 Jun 29, 2023 | FY 2022 Jun 29, 2022 | FY 2021 Jun 29, 2021 |
|---|---|---|---|---|---|---|
Revenue | 100K | 400K | 225K | n/a | 1.88M | 2.37M |
Cost of Revenue | n/a | n/a | n/a | n/a | 3.79M | 1.46M |
Gross Profit | 100K | 400K | 225K | n/a | -1.91M | 909K |
Operating Income | -35.14M | -18.6M | -16.63M | -29.34M | -29.7M | -31.11M |
Interest Income | 2.15M | 437K | 363K | 213K | 177K | 140K |
Pretax Income | -33.04M | -18.38M | -15.44M | -29.31M | -29.51M | -23.21M |
Net Income | -33.04M | -18.38M | -24.91M | -65.01M | -50.39M | -23.21M |
Selling & General & Admin | 10.6M | 10.69M | 11.67M | 18.45M | 17.96M | 21.89M |
Research & Development | 19.64M | 8.31M | 5.19M | 10.33M | 9.83M | 9.99M |
Other Expenses | 5M | n/a | n/a | 565K | n/a | 143K |
Operating Expenses | 35.24M | 19M | 16.86M | 29.34M | 27.79M | 32.02M |
Interest Expense | 53K | 212K | 172K | 83K | 1.41M | 2.45M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | 189K |
Cost & Expenses | 35.24M | 19M | 16.86M | 29.34M | 31.58M | 33.48M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 104.06M | 10.5M | 3.83M | 612.25K | 17.44K | 391.24K |
Shares Outstanding (Diluted) | 104.06M | 10.5M | 3.83M | 612.25K | 17.44K | 391.24K |
EPS (Basic) | -0.32 | -1.75 | -6.50 | -106.18 | -2.89K | -59.98 |
EPS (Diluted) | -0.32 | -1.75 | -6.50 | -106.18 | -2.89K | -59.98 |
EBITDA | -32.35M | -17.04M | -14.02M | -27.85M | -25.72M | -28.55M |
EBIT | -32.99M | -18.17M | -15.27M | -29.23M | -29.51M | -30.97M |
Depreciation & Amortization | 646K | 1.13M | 1.25M | 1.38M | 3.79M | 2.41M |
Add to Watchlist
Select watchlists to add or remove IBIO